BioWorld

May 11, 2015

View Archived Issues

As IPO market wanes, biotechs turn to reverse mergers

Through the first four months of the year, BioWorld Snapshots tracked 24 IPOs by drug companies on U.S. and international exchanges compared to 36 in the same time period last year. Read More

Week in review

Read More

Word on the street

Read More

Week in Washington

Read More

Biotech money raised by month in 2015

Read More

Public financing of biotechnology companies: Commenced trading in April 2015

Read More

Public financing of biotechnology companies: Filed and pending IPOs

Read More

2015 top private financings of public companies

Read More

Other financings of public biotechnology companies: April 2015

Read More

2015 top financings of private companies

Read More

Venture capital & other investments in private biotechnology companies: April 2015

Read More

Milestone payments from corporate partners: April 2015

Read More

Money raised by biotech in 2015 vs. 2014

Read More

Money raised by biotech Jan. 1 - May 7, 2015

Read More

Nasdaq Stock Index 2015

Read More

BioWorld Stock Index 2015

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More